menu

Cerebral Palsy Market

Schedule Call

Cerebral Palsy Market

Cerebral Palsy Market By Disease Type (Spastic Cerebral Palsy, Dyskinetic Cerebral Palsy, Ataxia Cerebral Palsy, and Mixed Cerebral Palsy), By Type (Diagnosis and Treatment), By End User (Hospitals, Specialty Clinics, Physiotherapy Centers, and Diagnostic Laboratories) - Global Outlook & Forecast 2022-2030

GR - 536575 Category: Pharmaceuticals

Number of pages: 100  |  Report Format: PDF  |  Published date: November 15, 2022

Historical Years – 2020  |  Base Year – 2021  |  Forecasted Years – 2022-2030


Cerebral Palsy Market Scope

Report Attribute

Details

Market size value in 2021

US$ 3.2 billion

Revenue forecast in 2030

US$ 4.25 billion

Growth Rate

CAGR of 3.2% from 2022 to 2030

Base year for estimation

2021

Forecast period

2022-2030

Segments covered

disease type, type, end user, and region.

Regional scope

North America, Europe, Asia Pacific, and the Rest of the World (ROW)

Report Overview

The global cerebral palsy market was pegged at US$ 3.2 billion in 2021 and is expected to witness a CAGR of 3.2% during the forecast period.

Market Fundamentals

Cerebral palsy is a term that describes a collection of neurological disorders that impede muscular movement and coordination. Damage to an infant's immature growing brain can result in cerebral palsy. In addition, asphyxia neonatorum, bleeding into the brain, brain infections, and severe jaundice in neonates are also possible causes of cerebral palsy. 

[323432]

Market Dynamic

The primary driving factor responsible for the global cerebral palsy market expansion is the global rise in cerebral palsy prevalence. Another factor influencing market growth is the increased focus on healthcare technological advancements together with the expanding accessibility of innovative cerebral palsy medications. Government campaigns to raise awareness, improved research and development capabilities, and an increased reliance on drugs to treat symptoms will all lead to profitable global cerebral palsy market expansion potential.

However, the high cost of drugs will slow the cerebral palsy market's expansion. Additional obstacles for the market will come from the side effects of the drugs, such as sleepiness, depression, headaches, lethargy, confusion, and dizziness. Additionally, a lack of awareness in poor and backward economies would slow market expansion.

Market Ecosystem

The global cerebral palsy market has been analyzed from three perspectives: disease type, type, end user, and region.

Cerebral Palsy Market by Disease Type

[1232434]

Based on disease type the global cerebral palsy market has been subdivided into, spastic cerebral palsy, dyskinetic cerebral palsy, ataxia cerebral palsy, mixed cerebral palsy, and others. The spastic cerebral palsy segment dominates the global cerebral palsy market. This is because most the cerebral palsy are suffering from spastic cerebral palsy, which results in stiffness of limb muscles causing difficulty in walking. 

Cerebral Palsy Market by Type

Based on type, the global cerebral palsy market has been divided into diagnosis and treatment. The diagnosis segment is further divided into, brain scans (MRI, CT, cranial ultrasound), electroencephalograms, and laboratory tests. The treatment segment is further divided into medications and another segment like surgery. The diagnosis segment dominated the global cerebral palsy segment. This is attributed to the introduction of various advanced diagnostic procedures available in the market. 

Cerebral Palsy Market by End User

Based on the end user, the global cerebral palsy market has been divided into hospitals, specialty clinics, physiotherapy centers, diagnostic laboratories, and others. The hospital segment dominates the global cerebral palsy market. This is attributed to the large patient footfall and availability of advanced diagnostic machinery and drugs in the hospital. 

Cerebral palsy Market by Region 

Based on region, the global cerebral palsy market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World. Most of the global market for cerebral palsy products is in North America. The country's high frequency of cerebral palsy is driving up demand for its treatments. As a result, pharmaceutical companies are making major investments in the therapeutic sector, which will greatly influence the market. Rising investments in the industry under study will spur innovation and increase access to cerebral palsy treatments, which will grow the market.

Competitive Landscape

Some of the prominent players operating in the global cerebral palsy market are: - 

  • Ipsen Biopharmaceuticals, Inc.
  • Supernus Pharmaceuticals, Inc.
  • Revance Therapeutics
  • Cellular Biomedicine Group, Inc.
  • Cell Cure Neurosciences
  • Meridigen Biotechnology
  • Merz Pharmaceuticals
  • Baylx, Inc.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.

Strategic Developments

• SpineX revealed its first-in-human trial in October 2022, which supports the use of their specialized non-surgical treatment for cerebral palsy in youngsters (CP).

• In February 2022, Hearts & Minds Investments Limited and the Cerebral Palsy Alliance Research Foundation (CPA) signed a significant new cooperation agreement. This relationship will support creative research that aims to transform newborn intensive care around the world.

Frequently Asked Questions About This Report

The global cerebral palsy market is expected to grow at a CAGR of 3.2% in the forecast period.

Ipsen Biopharmaceuticals, Inc., Supernus Pharmaceuticals, Inc., Revance Therapeutics, etc. are a few key players in the global cerebral palsy market.

The diagnostics segment dominates the global cerebral palsy market.

Asia Pacific region is expected to witness the highest global cerebral palsy market growth in the forecast period.

Table of Content

  1. INTRODUCTION
    1. Market Ecosystem 
    2. Timeline Under Consideration
      1. Historical Years – 2020
      2. Base Year – 2021
      3. Forecasted Years – 2022 to 2030
    3. Currency Used in the Report
  2. RESEARCH METHODOLOGY 
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
    4. Market Estimation Approach
      1. Bottom Up 
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions       
  3. PREMIUM INSIGHTS
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2021) 
  4. MARKET DYNAMICS
    1. Drivers
    2. Restraints/Challenges
    3. Opportunities
  5. GLOBAL CEREBRAL PALSY MARKET - ANALYSIS & FORECAST, BY DISEASE TYPE
    1. Spastic Cerebral Palsy
    2. Dyskinetic Cerebral Palsy
    3. Ataxia Cerebral Palsy
    4. Mixed Cerebral Palsy
    5. Others
  6. GLOBAL CEREBRAL PALSY MARKET - ANALYSIS & FORECAST, BY TYPE
    1. Diagnosis
      1. Brain Scans (MRI, CT, Cranial Ultrasound)
      2. Electroencephalogram
      3. Laboratory Tests
    2. Treatment
      1. Medication
        1. Anticholinergics
        2. Anticonvulsants
        3. Antispastic
        4. Antidepressants
        5. Anti-Inflammatory
        6.  Muscle Relaxants
        7. Benzodiazepines
        8. Nerve Blocks
        9. Botox
        10. Baclofen
        11. Others
      2. Therapy
        1.  Nutrition Therapy
        2. Physical Therapy
        3. Hyperbaric Oxygen Therapy 
        4. Occupational Therapy
        5. Stem Cell Therapy 
        6. Others
      3. Others (Surgery)
  7. GLOBAL CEREBRAL PALSY MARKET - ANALYSIS & FORECAST, BY END USER
    1. Hospitals
    2. Specialty Clinics
    3. Physiotherapy Centers
    4. Diagnostic Laboratories
    5. Others
  8. GLOBAL CEREBRAL PALSY MARKET - ANALYSIS & FORECAST, BY REGION
    1. North America Cerebral Palsy Market
      1. North America Cerebral Palsy Market, by Disease Type
      2. North America Cerebral Palsy Market, by Type
      3. North America Cerebral Palsy Market, by End User
      4. North America Cerebral Palsy Market, by Country
        1. U.S.
          1. U.S. Cerebral Palsy Market, by Disease Type
          2. U.S. Cerebral Palsy Market, by Type
          3. U.S. Cerebral Palsy Market, by End User
        2. Canada
          1. Canada Cerebral Palsy Market, by Disease Type
          2. Canada Cerebral Palsy Market, by Type
          3. Canada Cerebral Palsy Market, by End User
    2. Europe Cerebral Palsy Market
      1. Europe Cerebral Palsy Market, by Disease Type
      2. Europe Cerebral Palsy Market, by Type
      3. Europe Cerebral Palsy Market, by End User
      4. Europe Cerebral Palsy Market, by Country/Region
        1. Germany
          1. Germany Cerebral Palsy Market, by Disease Type
          2. Germany Cerebral Palsy Market, by Type
          3. Germany Cerebral Palsy Market, by End User
        2. U.K.
          1. U.K. Cerebral Palsy Market, by Disease Type
          2. U.K. Cerebral Palsy Market, by Type
          3. U.K. Cerebral Palsy Market, by End User
        3. Spain
          1. Spain Cerebral Palsy Market, by Disease Type
          2. Spain Cerebral Palsy Market, by Type
          3. Spain Cerebral Palsy Market, by End User
        4. Italy 
          1. Italy Cerebral Palsy Market, by Disease Type
          2. Italy Cerebral Palsy Market, by Type
          3. Italy Cerebral Palsy Market, by End User
        5. France
          1. France Cerebral Palsy Market, by Disease Type
          2. France Cerebral Palsy Market, by Type
          3. France Cerebral Palsy Market, by End User
        6. Rest of Europe 
          1. Rest of Europe Cerebral Palsy Market, by Disease Type
          2. Rest of Europe Cerebral Palsy Market, by Type
          3. Rest of Europe Cerebral Palsy Market, by End User
    3. Asia Pacific Cerebral Palsy Market
      1. Asia Pacific Cerebral Palsy Market, by Disease Type
      2. Asia Pacific Cerebral Palsy Market, by Type
      3. Asia Pacific Cerebral Palsy Market, by End User
      4. Asia Pacific Cerebral Palsy Market, by Country/Region
        1. China
          1. China Cerebral Palsy Market, by Disease Type
          2. China Cerebral Palsy Market, by Type
          3. China Cerebral Palsy Market, by End User
        2. Japan
          1. Japan Cerebral Palsy Market, by Disease Type
          2. Japan Cerebral Palsy Market, by Type
          3. Japan Cerebral Palsy Market, by  End User
        3. India
          1. India Cerebral Palsy Market, by Disease Type
          2. India Cerebral Palsy Market, by Type
          3. India Cerebral Palsy Market, by End User
        4. South Korea
          1. South Korea Cerebral Palsy Market, by Disease Type
          2. South Korea Cerebral Palsy Market, by Type
          3. South Korea Cerebral Palsy Market, by End User
        5. Australia
          1. Australia Cerebral Palsy Market, by Disease Type
          2. Australia Cerebral Palsy Market, by Type
          3. Australia Cerebral Palsy Market, by End User
        6. Rest of Asia Pacific 
          1. Rest of Asia Pacific Cerebral Palsy Market, by Disease Type
          2. Rest of Asia Pacific Cerebral Palsy Market, by Type
          3. Rest of Asia Pacific Cerebral Palsy Market, by End User
    4. Rest of the World Cerebral Palsy Market
      1. Rest of the World Cerebral Palsy Market, By Region
        1. Rest of the World Cerebral Palsy Market, by Disease Type
        2. Rest of the World Cerebral Palsy Market, by Type 
        3. Rest of the World Cerebral Palsy Market, by End User
        4. Latin America
          1. Latin America Cerebral Palsy Market, by Disease Type
          2. Latin America Cerebral Palsy Market, by Type
          3. Latin America Cerebral Palsy Market, by End User
        5. Middle East & Africa
          1. Middle East & Africa Cerebral Palsy Market, by Disease Type
          2. Middle East & Africa Cerebral Palsy Market, by Type
          3. Middle East & Africa Cerebral Palsy Market, by End User
  9. COMPANY PROFILES              
    1. Ipsen Biopharmaceuticals, Inc.
      1. Business Snapshot 
      2. Ingredient Procedures/Services Offered
      3. Financial Details*
      4. Strategic Developments
    2. Supernus Pharmaceuticals, Inc.
    3. Revance Therapeutics
    4. Cellular Biomedicine Group, Inc.
    5. Cell Cure Neurosciences
    6. Meridigen Biotechnology
    7. Merz Pharmaceuticals
    8. Baylx, Inc.
    9. Novartis AG
    10. Teva Pharmaceutical Industries Ltd.

*Insights on financial permanence are subject to the availability of information in the public domain


Single User License
Single User License
Multi User License
Enterprise User License
$4,750.00
Provides access to one user only and should not be shared with other employees within the organization.
Provides access to up to five users within the department or an organization.
Provides access to all the employees in the organization. The report can also be shared with subsidiaries, sister concerns and group entities.
Grants user/users’ access to quantitative data only, which includes but is not restricted to numeric data, tables, and charts as defined by Growth+ Reports.
  • What are the significant driving and restraining factors for the Cerebral Palsy Market?
  • Who are the leading companies in the market?
  • Where can you find the updates on recent developments by market players?
  • When is the right time to get discounts on complete market reports?
  • Why to invest in the Cerebral Palsy Market?
  • How to improve your organizational performance?
  • How to shift customers towards your brand?

Recommended Reports